Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Hypersensitivity | 2 | 2024 | 90 | 1.370 |
Why?
|
| Hypersensitivity | 2 | 2022 | 254 | 1.170 |
Why?
|
| Penicillins | 2 | 2024 | 62 | 0.990 |
Why?
|
| Amoxicillin | 1 | 2024 | 35 | 0.820 |
Why?
|
| Allergy and Immunology | 1 | 2022 | 43 | 0.720 |
Why?
|
| Remote Consultation | 1 | 2022 | 66 | 0.690 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 250 | 0.530 |
Why?
|
| Anti-Bacterial Agents | 2 | 2024 | 1922 | 0.470 |
Why?
|
| Telemedicine | 1 | 2022 | 956 | 0.360 |
Why?
|
| Asthma | 1 | 2022 | 1795 | 0.320 |
Why?
|
| Dermatitis, Atopic | 1 | 2008 | 322 | 0.220 |
Why?
|
| Skin Tests | 1 | 2024 | 94 | 0.210 |
Why?
|
| Receptor, Insulin | 4 | 1996 | 93 | 0.200 |
Why?
|
| Child | 5 | 2024 | 22670 | 0.200 |
Why?
|
| Alkyl and Aryl Transferases | 3 | 1997 | 31 | 0.190 |
Why?
|
| Insulin | 8 | 1998 | 2510 | 0.190 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 8 | 1998 | 254 | 0.180 |
Why?
|
| Electronics | 1 | 2022 | 65 | 0.180 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1997 | 165 | 0.160 |
Why?
|
| Organophosphonates | 2 | 1997 | 95 | 0.150 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 269 | 0.150 |
Why?
|
| Adipocytes | 3 | 1997 | 223 | 0.140 |
Why?
|
| Outpatients | 1 | 2022 | 447 | 0.140 |
Why?
|
| Protein Kinases | 1 | 1996 | 312 | 0.100 |
Why?
|
| Infant | 2 | 2024 | 10060 | 0.100 |
Why?
|
| Child, Preschool | 2 | 2024 | 11835 | 0.100 |
Why?
|
| Pandemics | 1 | 2022 | 1703 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2021 | 1293 | 0.090 |
Why?
|
| Humans | 9 | 2024 | 145140 | 0.090 |
Why?
|
| Guanosine Triphosphate | 4 | 1997 | 89 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 427 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 1996 | 45 | 0.060 |
Why?
|
| Enzyme Activation | 3 | 1996 | 762 | 0.060 |
Why?
|
| 3T3 Cells | 5 | 1997 | 156 | 0.060 |
Why?
|
| Protein Kinase C | 2 | 1996 | 251 | 0.060 |
Why?
|
| Adolescent | 1 | 2024 | 22479 | 0.050 |
Why?
|
| Farnesyltranstransferase | 3 | 1997 | 21 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1996 | 623 | 0.050 |
Why?
|
| Enzyme Inhibitors | 4 | 1997 | 820 | 0.040 |
Why?
|
| Male | 2 | 2024 | 72664 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 3410 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 2928 | 0.040 |
Why?
|
| Farnesol | 2 | 1997 | 5 | 0.040 |
Why?
|
| Transferases | 2 | 1997 | 27 | 0.040 |
Why?
|
| Female | 2 | 2024 | 78636 | 0.040 |
Why?
|
| Parents | 1 | 2008 | 1401 | 0.040 |
Why?
|
| Lovastatin | 2 | 1996 | 37 | 0.040 |
Why?
|
| Rats | 6 | 1998 | 5582 | 0.040 |
Why?
|
| Organophosphorus Compounds | 2 | 1997 | 84 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1998 | 85 | 0.030 |
Why?
|
| Growth Substances | 1 | 1997 | 138 | 0.030 |
Why?
|
| Immunosorbent Techniques | 1 | 1996 | 18 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1996 | 49 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1996 | 126 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1998 | 445 | 0.030 |
Why?
|
| Proteins | 3 | 1996 | 1022 | 0.030 |
Why?
|
| Phosphorylation | 2 | 1997 | 1706 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1995 | 66 | 0.030 |
Why?
|
| Mice | 6 | 1997 | 18303 | 0.030 |
Why?
|
| Animals | 9 | 1998 | 37952 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1996 | 442 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1996 | 693 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1995 | 587 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1996 | 1163 | 0.020 |
Why?
|
| Signal Transduction | 3 | 1996 | 5208 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1995 | 1479 | 0.020 |
Why?
|
| Drug Synergism | 2 | 1998 | 354 | 0.020 |
Why?
|
| ras GTPase-Activating Proteins | 2 | 1996 | 14 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 2 | 1996 | 81 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 1998 | 317 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1996 | 1368 | 0.010 |
Why?
|
| Fibroblasts | 2 | 1997 | 1022 | 0.010 |
Why?
|
| Glucose | 2 | 1996 | 1048 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1998 | 4142 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1998 | 78 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 1998 | 62 | 0.010 |
Why?
|
| Lymphokines | 1 | 1998 | 128 | 0.010 |
Why?
|
| Mevalonic Acid | 1 | 1997 | 12 | 0.010 |
Why?
|
| Protein Prenylation | 1 | 1997 | 19 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 449 | 0.010 |
Why?
|
| Flavonoids | 1 | 1997 | 85 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1997 | 161 | 0.010 |
Why?
|
| Son of Sevenless Proteins | 1 | 1996 | 4 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1996 | 31 | 0.010 |
Why?
|
| Chromones | 1 | 1996 | 43 | 0.010 |
Why?
|
| Mitogens | 1 | 1996 | 55 | 0.010 |
Why?
|
| CHO Cells | 1 | 1996 | 169 | 0.010 |
Why?
|
| Swine | 1 | 1998 | 822 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1998 | 552 | 0.010 |
Why?
|
| Cricetinae | 1 | 1996 | 302 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1996 | 295 | 0.010 |
Why?
|
| Activating Transcription Factor 1 | 1 | 1995 | 9 | 0.010 |
Why?
|
| Morpholines | 1 | 1996 | 130 | 0.010 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 1995 | 8 | 0.010 |
Why?
|
| Glycogen | 1 | 1995 | 55 | 0.010 |
Why?
|
| Protein Phosphatase 2 | 1 | 1995 | 41 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1995 | 190 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1995 | 63 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1995 | 146 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1996 | 382 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1996 | 1177 | 0.010 |
Why?
|
| Cell Division | 1 | 1995 | 753 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 1048 | 0.010 |
Why?
|
| Transfection | 1 | 1995 | 926 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1998 | 2803 | 0.000 |
Why?
|
| Cell Line | 1 | 1995 | 2821 | 0.000 |
Why?
|
| Transcription Factors | 1 | 1995 | 1731 | 0.000 |
Why?
|